StockDriftsStockDriftsTop 45 Avidity Partners Management LP Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| DNTH | DIANTHUS THERAPEUTICS INC | 35.76% | 2.10M | $176.6M | +0.00%(+0) | $22.85(+312.79%) | 2026-03-31 | |
| CGON | CG ONCOLOGY INC | 17.67% | 1.29M | $87.2M | -12.48%(-183.75K) | $36.26(+94.07%) | 2026-03-31 | |
| ORKA | ORUKA THERAPEUTICS INC | 7.55% | 760.4K | $37.3M | +15.14%(+100.00K) | $27.70(+207.56%) | 2026-03-31 | |
| CATX | PERSPECTIVE THERAPEUTICS INC | 5.11% | 6.05M | $25.2M | +88.43%(+2.84M) | $5.76(-37.03%) | 2026-03-31 | |
| JBIO | JADE BIOSCIENCES INC | 3.99% | 1.40M | $19.7M | +0.00%(+0) | $42.00(-48.78%) | 2026-03-31 | |
| ELVN | ENLIVEN THERAPEUTICS INC | 3.18% | 400.0K | $15.7M | +185.10%(+259.70K) | $24.86(+100.44%) | 2026-03-31 | |
| TEVA | TEVA PHARM ADR | 2.75% | 450.1K | $13.6M | +7.86%(+32.80K) | $18.80(+84.30%) | 2026-03-31 | |
| CNTX | CONTEXT THERAPEUTICS INC | 2.65% | 5.00M | $13.1M | -9.20%(-506.59K) | $1.54(-57.64%) | 2026-03-31 | |
| RGEN | REPLIGEN CORP | 1.86% | 77.8K | $9.2M | +54.67%(+27.50K) | $140.01(+1.70%) | 2026-03-31 | |
| PVLA | PALVELLA THERAPEUTICS INC | 1.77% | 70.0K | $8.7M | +262.69%(+50.70K) | $106.12(+38.30%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +21.29% | +78.41% |
| Top 20 Holdings Unweighted | +10.96% | +36.63% |
Sign up free to track Avidity Partners Management LP, compare funds side by side, and get alerts the moment positions change.